|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：R538002 |
| 產(chǎn)品名稱：Rivaroxaban-d4 |
| 產(chǎn)品CAS：1132681-38-9 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
R538002 |
| 名稱: |
Rivaroxaban-d4 |
| 別名: |
5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl-d4]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide; BAY 59-7939-d4; |
| CAS號: |
1132681-38-9 |
| 參考CAS號: |
366789-02-8-unlabelled |
| 分子式: |
C??H??D?ClN?O?S |
| 外觀: |
白色至白色固體 |
| 熔點: |
224 - 225°C |
| 分子量: |
439.91 |
| 儲存: |
冰箱 |
| 溶解度: |
DMSO (Slightly), Methanol (Very Slightly, Heated) |
| 類別: |
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
A novel labelled antithrombotic agent. A highly potent and selective, direct FXa inhibitor. |
| 參考文獻 |
|
|
|
|
|
|
?您的位置：
